These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25817231)

  • 1. Evaluation of serum midkine as a biomarker in differentiated thyroid cancer.
    Meng Z; Tan J; Zhang G; Tian W; Fu Q; Li W; He X; Wu S; Yang Z; Liang X; Dong L; Zhang Q; Liu L; Zhang Y; Xu K; Liu B; Li N; Li X; Jia Q; He Y; Wang S; Wang R; Zheng W; Song X; Zhang J; Hu T; Liu N; Upadhyaya A
    Life Sci; 2015 Jun; 130():18-24. PubMed ID: 25817231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody.
    Jia Q; Meng Z; Xu K; He X; Tan J; Zhang G; Li X; Liu N; Hu T; Zhou P; Wang S; Upadhyaya A; Liu X; Wang H; Zhang C
    Sci Rep; 2017 Feb; 7():43516. PubMed ID: 28240744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
    Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
    Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
    Boi F; Baghino G; Atzeni F; Lai ML; Faa G; Mariotti S
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1364-9. PubMed ID: 16434461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer.
    Pacini F; Fugazzola L; Lippi F; Ceccarelli C; Centoni R; Miccoli P; Elisei R; Pinchera A
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1401-4. PubMed ID: 1592886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis.
    Zhang Y; Meng Z; Zhang M; Tan J; Tian W; He X; Fu Q; Xu K; He Q; Zhu M; Li X; Zhang G; He Y; Jia Q; Zhang J; Wang S; Song X
    Life Sci; 2014 Nov; 118(1):39-45. PubMed ID: 25283079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer.
    Chinnappa P; Taguba L; Arciaga R; Faiman C; Siperstein A; Mehta AE; Reddy SK; Nasr C; Gupta MK
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3705-9. PubMed ID: 15292293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of three-week thyroglobulin test in patients with thyroid cancer undergoing thyroidectomy].
    Vasil'ev DA; Poroshina TE; Radzhabova ZA; Bershteĭn LM
    Vopr Onkol; 2012; 58(4):481-5. PubMed ID: 23607201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High sensitive thyroglobulin assay on thyroxine therapy: can it avoid stimulation test in low and high risk differentiated thyroid carcinoma patients?
    Trimboli P; La Torre D; Ceriani L; Condorelli E; Laurenti O; Romanelli F; Ventura C; Signore A; Valabrega S; Giovanella L
    Horm Metab Res; 2013 Sep; 45(9):664-8. PubMed ID: 23720229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focus on high-risk DTC patients: high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to progression-free survival and overall survival.
    Piccardo A; Arecco F; Puntoni M; Foppiani L; Cabria M; Corvisieri S; Arlandini A; Altrinetti V; Bandelloni R; Orlandi F
    Clin Nucl Med; 2013 Jan; 38(1):18-24. PubMed ID: 23242039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of thyroglobulin assay in cervical lymph node fine-needle aspirations for metastatic differentiated thyroid cancer.
    Giovanella L; Bongiovanni M; Trimboli P
    Curr Opin Oncol; 2013 Jan; 25(1):6-13. PubMed ID: 23090642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with differentiated thyroid cancer have a venous gradient in thyroglobulin levels.
    Kebebew E; Reiff E
    Cancer; 2007 Mar; 109(6):1078-81. PubMed ID: 17279579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors.
    Song HJ; Qiu ZL; Shen CT; Wei WJ; Luo QY
    Eur J Endocrinol; 2015 Sep; 173(3):399-408. PubMed ID: 26104753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
    Spencer CA
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroglobulin as early prognostic marker to predict remission at 18-24 months in differentiated thyroid carcinoma.
    González C; Aulinas A; Colom C; Tundidor D; Mendoza L; Corcoy R; Mato E; Alcántara V; Urgell Rull E; de Leiva A
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):301-6. PubMed ID: 23826916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3947 patients.
    Webb RC; Howard RS; Stojadinovic A; Gaitonde DY; Wallace MK; Ahmed J; Burch HB
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2754-63. PubMed ID: 22639291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis.
    Wang C; Zhang X; Li H; Li X; Lin Y
    PLoS One; 2017; 12(7):e0179664. PubMed ID: 28704384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitive 2nd generation thyroglobulin immunoradiometric assay. Clinical application in differentiated thyroid cancer management.
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2002 Dec; 46(4):319-22. PubMed ID: 12411872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.